ERBB2 and breast cancer: The MDA-MB-231 human breast cancer cell line is negative for both matriptase and HAI-1 [15], but is apparently capable of supporting the role of matriptase to cleave Her2 and the re-expressed matriptase is responsive to a re-expressed HAI-1 (Figure 6).